Visualization and Quantification of Neurokinin-1 (NK1) Receptors in the Human Brain

This publication has 59 references indexed in Scilit:

• Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK receptor quantitation: ([F]SPA-RQ)
  Molecular Imaging & Biology, 2004
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists
  European Journal Of Cancer, 2003
• Neuropeptides — an overview
  Neuropharmacology, 2000
• Rewarding effects of opiates are absent in mice lacking the receptor for substance P
  Nature, 2000
• The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets
  Neuropharmacology, 2000
• Comparison of the Transient Equilibrium and Continuous Infusion Method for Quantitative PET Analysis of [¹¹C]Raclopride Binding
  Journal of Cerebral Blood Flow & Metabolism, 1998
• Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets
  Neuropharmacology, 1996
• Striatal neurones displaying substance P (NK 1) receptor immunoreactivity in human and non-human primates
  NeuroReport, 1995
• A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor
  Science, 1991
• Compartmental Analysis of Diprenorphine Binding to Opiate Receptors in the Rat in vivo and its Comparison with Equilibrium Data in vitro
  Journal of Cerebral Blood Flow & Metabolism, 1991